These results were in line with Mikami et al.’s study which illustrated that TLR-4 inhibits tumor growth in cutaneous squamous cell carcinoma (SCC), and TLR-4 knockdown enhances the migration and invasion in SCC cells (40). Here, TLR4 is linked to neoplasm.